Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Plenary Session 4: The Role of Liquid Biopsies in Guiding Cancer Therapeutics-- Detection, Response Monitoring, and Resistance

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
Plenary Session 4: The Role of Liquid Biopsies in Guiding Cancer Therapeutics-- Detection, Response Monitoring, and Resistance
Background and use of circulating tumor-derived DNA and circulating tumor cells as biomarkers
Martijn Lolkema
Erasmus MC, Rotterdam, Netherlands
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 10:00 AM-11:45 AM
Plenary Session 4: The Role of Liquid Biopsies in Guiding Cancer Therapeutics-- Detection, Response Monitoring, and Resistance
  •  
  • Free
  • Coming soon
  • Some slides withheld
  •  
  •  
Extracellular vesicles as opportunities for integrative or focused liquid biopsy studies
Jennifer Jones
National Cancer Institute, Bethesda, MD, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 10:00 AM-11:45 AM
Plenary Session 4: The Role of Liquid Biopsies in Guiding Cancer Therapeutics-- Detection, Response Monitoring, and Resistance
Clinical implications of serial analysis of circulating tumor DNA in patients with stages I to III colorectal cancer
Claus L. Andersen
Aarhus University Hospital, Aarhus, Denmark
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 10:00 AM-11:45 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3